RxDoctor Payments Data

John Mahoney, MD

Orthopaedic Surgery · Danville, VANPI 1578544912

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Exactech, Inc. accounts for 63.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $3,194 and has fallen 95.3% since, to $150 in 2025.

$4,554in general payments, 2019–2025

Across 53 payments — averaging $85.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exactech, Inc.$3K
  • Encore Medical, LP$439
  • Amgen$379
  • Pacira Therapeutics, Inc.$341
  • Johnson & Johnson$147
  • Pacira Pharmaceuticals Incorporated$114
  • plus $254 from 9 others
$560,052in research payments, 2019–2025

Across 60 payments — averaging $9334.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo Pharmaceuticals Inc.$507K
  • Pacira Therapeutics, Inc.$53K

What the payments were for

  • Speaking & faculty fees$501%
  • Travel & lodging$2,08646%
  • Food & beverage$2,41853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,554 in reported general payments places this provider in the 55th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$237,473
Medicare patients
477
Services billed
7,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone132$1,196
Diclofenac Sodium94$1,189
Colchicine15$562
Ibuprofen87$551
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen93$513
Meloxicam190$466
Baclofen79$353
Allopurinol43$265
Cyclobenzaprine Hcl36$260
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$182
Gabapentin29$157
Tramadol Hcl52$133
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$25

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Danville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →